tiprankstipranks
Acotec Scientific Holdings Limited (DE:7W3)
FRANKFURT:7W3
Want to see DE:7W3 full AI Analyst Report?

Acotec Scientific Holdings Limited (7W3) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Acotec Scientific Holdings Limited has a market cap or net worth of €347.85M. The enterprise value is €2.32B.
Market Cap€347.85M
Enterprise Value€2.32B

Share Statistics

Acotec Scientific Holdings Limited has 313,389,160 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding313,389,160
Owned by Insiders
Owned by Institutions

Financial Efficiency

Acotec Scientific Holdings Limited’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 4.41%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)4.41%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee966.07K
Profits Per Employee178.61K
Employee Count650
Asset Turnover0.34
Inventory Turnover1.38

Valuation Ratios

The current PE Ratio of Acotec Scientific Holdings Limited is 31.5. Acotec Scientific Holdings Limited’s PEG ratio is 0.24.
PE Ratio31.5
PS Ratio5.83
PB Ratio2.48
Price to Fair Value2.48
Price to FCF25.15
Price to Operating Cash Flow16.63
PEG Ratio0.24

Income Statement

In the last 12 months, Acotec Scientific Holdings Limited had revenue of 627.95M and earned 116.10M in profits. Earnings per share was 0.39.
Revenue627.95M
Gross Profit452.28M
Operating Income78.21M
Pretax Income119.02M
Net Income116.10M
EBITDA131.29M
Earnings Per Share (EPS)0.39

Cash Flow

In the last 12 months, operating cash flow was 194.51M and capital expenditures -35.51M, giving a free cash flow of 159.00M billion.
Operating Cash Flow194.51M
Free Cash Flow159.00M
Free Cash Flow per Share0.51

Dividends & Yields

Acotec Scientific Holdings Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.11
52-Week Price Change19.55%
50-Day Moving Average1.35
200-Day Moving Average1.37
Relative Strength Index (RSI)43.56
Average Volume (3m)40.00

Important Dates

Acotec Scientific Holdings Limited upcoming earnings date is Sep 2, 2026, TBA (Confirmed).
Last Earnings DateMar 26, 2026
Next Earnings DateSep 2, 2026
Ex-Dividend Date

Financial Position

Acotec Scientific Holdings Limited as a current ratio of 5.73, with Debt / Equity ratio of 16.36%
Current Ratio5.73
Quick Ratio5.19
Debt to Market Cap0.03
Net Debt to EBITDA-1.18
Interest Coverage Ratio7.82

Taxes

In the past 12 months, Acotec Scientific Holdings Limited has paid 2.92M in taxes.
Income Tax2.92M
Effective Tax Rate0.02

Enterprise Valuation

Acotec Scientific Holdings Limited EV to EBITDA ratio is 26.68, with an EV/FCF ratio of 0.00.
EV to Sales5.58
EV to EBITDA26.68
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00

Balance Sheet

Acotec Scientific Holdings Limited has €995.38M in cash and marketable securities with €236.13M in debt, giving a net cash position of €759.24M billion.
Cash & Marketable Securities€995.38M
Total Debt€236.13M
Net Cash€759.24M
Net Cash Per Share€2.42
Tangible Book Value Per Share€4.54

Margins

Gross margin is 74.84%, with operating margin of 12.45%, and net profit margin of 18.49%.
Gross Margin74.84%
Operating Margin12.45%
Pretax Margin18.95%
Net Profit Margin18.49%
EBITDA Margin20.91%
EBIT Margin12.45%

Analyst Forecast

The average price target for Acotec Scientific Holdings Limited is €1.85, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€1.85
Price Target Upside25.97% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast16.13%
EPS Growth Forecast121.52%

Scores

Smart ScoreN/A
AI Score